Plain-English translation of NCT06044506 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage study testing — a treatment where doctors take immune cells from your own blood, grow more of them in a laboratory, and infuse them back into your body to fight liver cancer. The trial is designed to find the right dose of these cells, understand what side effects might occur, and see how long patients stay cancer-free after treatment.
Liver cancer is difficult to treat, especially when it has spread or cannot be surgically removed. This medication uses your own immune system cells to potentially attack cancer in a new way, offering hope for patients who may have limited treatment options.
You likely qualify if…
You likely don't qualify if…
You would first have blood drawn so doctors can isolate your natural killer immune cells and grow them in the laboratory over several weeks. Once enough cells are ready, you would receive an intravenous infusion of your own grown cells back into your body. Your doctors will monitor you closely over several weeks to months to watch for side effects, measure how well the treatment works, and track how long you remain cancer-free.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Indonesia